Cerebrovascular Accident Clinical Trial
Background:Accelerometry has only recently been introduced in clinical stroke research.
However, whether accelerometry is a valid and reliable tool in stroke needs to be
established. From literature becomes clear that existing accelerometers show shortages at
patients with stroke because of the specific deficits that these patients have.
Purpose: The aim of this study is to investigate the validity and test-retest reliability of
the SenseWear Pro armband as an objective measurement of physical activity in chronic stroke
patients.
Patients and Methods Subjects: Fifteen patients and fifteen healthy subjects will be
included in the study following written informed consent. The following demographic and
clinical data were recorded: age, gender, height, length, medication use, self-reported
handedness, Edinburgh Handedness Inventory, Rivermead Gross Function, Functional Ambulation
Categories, medical and surgical history.
Methods: During one test session the subjects had to carry out an amount of activities
according to a standardised protocol existing of lying down, sitting, standing, walking,
step exercise and cycling. These activities are presenting activities of daily living.
Measures:Subjects wear on both arms a SenseWear Pro Armband. De data from these measuring
devices will be compared with the data retrieved from 2 Yamax pedometers and the
ergospirometry device. The outcome measures are: counts, heartbeat, oxygen used, energy
expenditure, METabolic equivalent, time lying down.
Evaluation of the SenseWear Pro Armband to assess physical activity in individuals with
chronic stroke
Background:
Accelerometry has only recently been introduced in clinical stroke research. However,
whether accelerometry is a valid and reliable tool in stroke needs to be established. From
literature becomes clear that existing accelerometers show shortages at patients with stroke
because of the specific deficits that these patients have.
Purpose:
The aim of this study is to investigate the validity and test-retest reliability of the
SenseWear Pro armband as an objective measurement of physical activity in chronic stroke
patients.
Patients and Methods Subjects Fifteen patients and fifteen healthy subjects will be included
in the study following written informed consent. The following demographic and clinical data
were recorded: age, gender, height, length, medication use, self-reported handedness,
Edinburgh Handedness Inventory, Rivermead Gross Function, Functional Ambulation Categories,
medical and surgical history.
Methods During one test session the subjects had to carry out an amount of activities
according to a standardised protocol existing of lying down, sitting, standing, walking,
step exercise and cycling. These activities are presenting activities of daily living.
Measures:
Subjects wear on both arms a SenseWear Pro Armband. De data from these measuring devices
will be compared with the data retrieved from 2 Yamax pedometers and the ergospirometry
device. The outcome measures are: counts, heartbeat, oxygen used, energy expenditure,
METabolic equivalent, time lying down.
;
Observational Model: Case Control, Time Perspective: Cross-Sectional
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05477238 -
Oxygen Consumption in Post-stroke Patients During Various Walking Activities Compared to Healthy Controls
|
N/A | |
| Completed |
NCT00046293 -
ReoPro and Retavase to Treat Acute Stroke
|
Phase 2 | |
| Completed |
NCT04584645 -
A Digital Flu Intervention for People With Cardiovascular Conditions
|
N/A | |
| Completed |
NCT01116544 -
Treatment of Chronic Stroke With AMES + EMG Biofeedback
|
N/A | |
| Withdrawn |
NCT04991038 -
Clinical Investigation to Compare Safety and Efficacy of DAISE and Stent Retrievers for Thrombectomy In Acute Ischemic Stroke Patients
|
N/A | |
| Active, not recruiting |
NCT02563886 -
Electrically Assisted Movement Therapy
|
N/A | |
| Recruiting |
NCT02446730 -
Efficacy and Safety of BiomatrixTM Stent and 5mg-Maintenance Dose of Prasugrel in Patients With Acute Coronary Syndrome
|
Phase 4 | |
| Completed |
NCT02141932 -
Pocket-size Cardiovascular Ultrasound in Stroke
|
N/A | |
| Completed |
NCT01915368 -
Determining Optimal Post-Stroke Exercise (DOSE)
|
N/A | |
| Recruiting |
NCT02557737 -
Botulinim Toxin Type A Injections by Different Guidance in Stroke Patients With Spasticity on Upper Extremities
|
Phase 3 | |
| Recruiting |
NCT01769326 -
Influence of Timing on Motor Learning
|
N/A | |
| Terminated |
NCT01705353 -
The Role of HMGB-1 in Chronic Stroke
|
N/A | |
| Completed |
NCT01423201 -
Transient Ischemic Attack (TIA) Triage and Evaluation of Stroke Risk
|
||
| Completed |
NCT01182818 -
Fabry and Stroke Epidemiological Protocol (FASEP): Risk Factors In Ischemic Stroke Patients With Fabry Disease
|
N/A | |
| Completed |
NCT01656876 -
The Effects of Mirror Therapy on Upper Extremity in Stroke Patients
|
N/A | |
| Completed |
NCT00542256 -
tDCS and Physical Therapy in Stroke
|
N/A | |
| Withdrawn |
NCT00573092 -
Analyzing Gene Regions That May Interact With the Effectiveness of High Blood Pressure Drugs
|
N/A | |
| Completed |
NCT00377689 -
Evaluation of an Intervention Program Targeted at Improving Balance and Functional Skills After Stroke
|
Phase 2 | |
| Recruiting |
NCT00166751 -
Sonographic Assessment of Laryngeal Elevation
|
N/A | |
| Terminated |
NCT00120289 -
Niacin Plus Statin to Prevent Vascular Events
|
Phase 3 |